Saurav Chemicals is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 6 molecules. Customs aggregates show $4.7M of exports covering 53 molecules to 22 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Atropine | SFDA (Saudi Arabia) | 1 |
| Celecoxib | US FDA | 1 |
| Chlorzoxazone | US FDA | 1 |
| Dexketoprofen | SFDA (Saudi Arabia) | 1 |
| Pregabalin | SFDA (Saudi Arabia) | 1 |
| Vildagliptin | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $4.7M | 22 |
| 2024 | Not reported | $22.6M | 51 |
| 2023 | Not reported | $39.8M | 45 |
| 2022 | Not reported | $24.0M | 50 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Saurav Chemicals, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.